You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 2, February 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Substance P, Insulinlike Growth Factor 1, and Surface Healing

Arch Ophthalmol. 2002;120:215-217.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Impaired adhesion, migration, and/or mitosis can compromise corneal epithelial healing. Persistent epithelial defects can progress to ulceration, perforation, or endophthalmitis. Currently, our options are limited to methods that address the underlying cause of the epithelial defect. In addition to addressing exposure keratopathy, mechanical irritation to the eye, and systemic diseases, clinicians supplement the tear film, minimize the mechanical aspects of delayed wound healing, and use collagenolytic enzyme inhibitors. Specific therapy includes preservative-free artificial tears, pressure patching, bandage contact lens, and N-acetylcysteine. The more recent use of nerve growth factor,1 amniotic membrane transplantation,2-4 and scleral lens2 has been reported. Nonsurgical therapeutic options have limited effect, and surgical procedures such as lamellar or penetrating keratoplasty become necessary to preserve the anatomic integrity of the globe. Vision-threatening procedures (Gunderson flap, tarsorrhaphy, evisceration, or enucleation) may also become necessary.

Recently, growth factors,1, 5-8 neuropeptides,5-8 and fibronectin6 have promoted epithelial wound healing. Topical substance P . . . [Full Text of this Article]

Report of a Case


Comment
Corresponding author and reprints: Neal P. Barney, MD, Department of Ophthalmology and Visual Sciences, University of Wisconsin, 2870 University Ave, Suite 206, Madison, WI 53705 (e-mail: npbarney@facstaff.wisc.edu).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prospective Tests on Biological Models of Acupuncture
Shang
Evid Based Complement Alternat Med 2007;0:nem122v1-nem122.
ABSTRACT | FULL TEXT  

Sensitizing Effect of Substance P on Corneal Epithelial Migration Induced by IGF-1, Fibronectin, or Interleukin-6
Yamada et al.
IOVS 2005;46:833-839.
ABSTRACT | FULL TEXT  

Vesicular Eruption in a Child With Trigeminal Nerve Palsy During Topical Therapy With Substance P and Insulinlike Growth Factor I for Neurotrophic Keratitis
Brown et al.
Arch Ophthalmol 2004;122:1722-1723.
FULL TEXT  

Insulin, Not Leptin, Promotes In Vitro Cell Migration to Heal Monolayer Wounds in Human Corneal Epithelium
Shanley et al.
IOVS 2004;45:1088-1094.
ABSTRACT | FULL TEXT  

Role of the C Domain of IGFs in Synergistic Promotion, with a Substance P-Derived Peptide, of Rabbit Corneal Epithelial Wound Healing
Yamada et al.
IOVS 2004;45:1125-1131.
ABSTRACT | FULL TEXT  

The Effect of Chronic Corneal Epithelial Debridement on Epithelial and Stromal Morphology in Dogs
Bentley et al.
IOVS 2002;43:2136-2142.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.